The compelling importance of NLRP3 as a target for the treatment of inflammatory and autoimmune diseases highlights the urgent need to develop highly specific and potent NLRP3 inflammasome inhibitors with as few adverse effects as possible [132]. The gene discussed is NLRP3; the disease is autoimmune disease.